Skip to main content

Advertisement

Table 2 Characteristics of PCa patients and controls

From: Association of genetic polymorphisms in the interleukin-10 promoter with risk of prostate cancer in Chinese

Characteristics Patients, n (%) (n = 262) Controls, n (%) (n = 270) P
Age    
<50 8(3.0) 9(3.3) 0.729
50-59 18(6.9) 20(7.4)  
60-69 83(31.7) 86(31.9)  
70-79 123(46.9) 130(48.1)  
≥80 30(11.5) 25(9.3)  
Average age 70.7 ± 8.4 70.2 ± 8.5  
Smoking status    
Nonsmoking 102 (38.9%) 109(40.4%) 0.734
smoking 160(61.1%) 161(59.6%)  
History of prostate cancer    
Yes 14(5.3) 6(2.2) 0.067
No 248(94.7) 264(97.8)  
PSA (ng/ml)    
Average concentration 128.33 ± 634.21 2.146 ± 0.954 <0.001
≤10 80(30.5)   
>10 182(69.5)   
Gleason score    
≤7 72(27.5)   
>7 161(62.5)   
missing 29(11.0)   
Clinical T Stage    
≤T2 93(35.5)   
>T2 156(59.5)   
missing 13(5.0)   
Agressive status    
Early stage 72(27.5)   
Advanced stage 180(68.7)   
missing 10(3.8)